Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 5
1984 1
1985 4
1986 2
1987 1
1988 5
1989 3
1990 6
1991 15
1992 7
1993 9
1994 9
1995 9
1996 13
1997 10
1998 11
1999 8
2000 18
2001 13
2002 11
2003 8
2004 9
2005 20
2006 11
2007 13
2008 16
2009 13
2010 10
2011 23
2012 30
2013 28
2014 14
2015 19
2016 16
2017 11
2018 4
2019 3
2020 4
2021 2
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Results by year

Filters applied: . Clear all
Page 1
Susceptibility to exacerbation in chronic obstructive pulmonary disease.
Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Hurst JR, et al. Among authors: macnee w. N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883. N Engl J Med. 2010. PMID: 20843247 Free article.
Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.
Lange P, Halpin DM, O'Donnell DE, MacNee W. Lange P, et al. Among authors: macnee w. Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss(Spec Iss):3-12. doi: 10.2147/COPD.S85976. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 26937185 Free PMC article. Review.
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).
Cotton S, Devereux G, Abbas H, Briggs A, Campbell K, Chaudhuri R, Choudhury G, Dawson D, De Soyza A, Fielding S, Gompertz S, Haughney J, Lang CC, Lee AJ, MacLennan G, MacNee W, McCormack K, McMeekin N, Mills NL, Morice A, Norrie J, Petrie MC, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Lipworth BJ. Cotton S, et al. Among authors: macnee w. Trials. 2022 Apr 14;23(1):307. doi: 10.1186/s13063-022-06226-8. Trials. 2022. PMID: 35422024 Free PMC article. Clinical Trial.
Beta-Blockers in COPD - A Controversy Resolved?
MacNee W. MacNee W. N Engl J Med. 2019 Dec 12;381(24):2367-2368. doi: 10.1056/NEJMe1912664. Epub 2019 Oct 20. N Engl J Med. 2019. PMID: 31633892 No abstract available.
Ultrafine particles.
Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. Donaldson K, et al. Among authors: macnee w. Occup Environ Med. 2001 Mar;58(3):211-6, 199. doi: 10.1136/oem.58.3.211. Occup Environ Med. 2001. PMID: 11171936 Free PMC article. Review. No abstract available.
Response.
Maclay JD, MacNee W. Maclay JD, et al. Among authors: macnee w. Chest. 2013 Sep;144(3):1081-1082. doi: 10.1378/chest.13-1352. Chest. 2013. PMID: 24008965 No abstract available.
Oxidants and COPD.
MacNee W. MacNee W. Curr Drug Targets Inflamm Allergy. 2005 Dec;4(6):627-41. doi: 10.2174/156801005774912815. Curr Drug Targets Inflamm Allergy. 2005. PMID: 17305519 Review.
392 results